We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+1.87%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$54.1B
AUM Growth
+$173M
(+0.32%)
Cap. Flow
-$378M
Cap. Flow
% of AUM
-0.7%
Top 10 Holdings %
Top 10 Hldgs %
28.08%
Holding
1,429
New
–
Increased
4
Reduced
11
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deutsche Bank
DB
|
+$1.28M |
| 2 |
Qiagen
QGEN
|
+$78.4K |
| 3 |
MAXN
Maxeon Solar Technologies
MAXN
|
+$37.3K |
| 4 |
FTC Solar
FTCI
|
+$35.3K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TE Connectivity
TEL
|
+$139M |
| 2 |
Arista Networks
ANET
|
+$107M |
| 3 |
Palo Alto Networks
PANW
|
+$66.8M |
| 4 |
Lam Research
LRCX
|
+$42.2M |
| 5 |
WIRE
Encore Wire Corp
WIRE
|
+$10.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.38% |
| 2 | Healthcare | 15.22% |
| 3 | Financials | 11.28% |
| 4 | Consumer Discretionary | 10.7% |
| 5 | Industrials | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Oracle
ORCL
$432B
| $227M | 0.42% |
1,354,438
| – | – |
|
52
Eaton
ETN
$173B
| $225M | 0.42% |
673,631
| – | – |
|
53
Republic Services
RSG
$65.9B
| $223M | 0.41% |
1,105,327
| – | – |
|
54
Stellantis
STLA
$21.2B
| $220M | 0.41% |
16,978,909
| – | – |
|
55
Booking.com
BKNG
$158B
| $219M | 0.4% |
1,100,450
| – | – |
|
56
Bristol-Myers Squibb
BMY
$133B
| $215M | 0.4% |
3,782,490
| – | – |
|
57
Analog Devices
ADI
$188B
| $215M | 0.4% |
999,243
| – | – |
|
58
Texas Instruments
TXN
$257B
| $206M | 0.38% |
1,088,670
| – | – |
|
59
Vertex Pharmaceuticals
VRTX
$135B
| $205M | 0.38% |
506,457
| – | – |
|
60
KLA
KLAC
$253B
| $205M | 0.38% |
3,174,200
| – | – |
|
61
Sempra
SRE
$55.6B
| $204M | 0.38% |
2,332,884
| – | – |
|
62
Intuit
INTU
$91B
| $200M | 0.37% |
314,704
| – | – |
|
63
Pfizer
PFE
$155B
| $196M | 0.36% |
7,398,373
| – | – |
|
64
ConocoPhillips
COP
$147B
| $195M | 0.36% |
2,028,920
| – | – |
|
65
Xylem
XYL
$28.5B
| $193M | 0.36% |
1,656,369
| – | – |
|
66
Blackrock
BLK
$175B
| $193M | 0.36% |
265,494
| – | – |
|
67
Gilead Sciences
GILD
$166B
| $190M | 0.35% |
2,040,494
| – | – |
|
68
Medtronic
MDT
$114B
| $189M | 0.35% |
2,351,765
| – | – |
|
69
Amgen
AMGN
$224B
| $185M | 0.34% |
711,647
| – | – |
|
70
Progressive
PGR
$125B
| $182M | 0.34% |
762,179
| – | – |
|
71
Broadcom
AVGO
$2.01T
| $179M | 0.33% |
757,234
| – | – |
|
|
ANSS
72
DELISTED
Ansys
ANSS
| $169M | 0.31% |
503,319
| – | – |
|
73
Quanta Services
PWR
$99.9B
| $165M | 0.31% |
517,038
| – | – |
|
74
Boston Scientific
BSX
$73.4B
| $165M | 0.3% |
1,844,793
| – | – |
|
75
CME Group
CME
$95.9B
| $160M | 0.3% |
685,973
| – | – |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q4 2024 Portfolio in Review
As of Q4 2024, DekaBank Deutsche Girozentrale held 1,429 positions worth $54.1B, up 0.32% from $53.9B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 0.77%. DekaBank Deutsche Girozentrale opened no new positions and exited 11, leaving the 1,429-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- DekaBank Deutsche Girozentrale added most to Deutsche Bank in Q4 2024, an estimated $1.28M increase.
- DekaBank Deutsche Girozentrale's biggest Q4 2024 reduction was Arista Networks, cutting an estimated $107M.
- DekaBank Deutsche Girozentrale fully exited TE Connectivity in Q4 2024, selling an estimated $139M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 28% of its $54.1B portfolio in Q4 2024.
- DekaBank Deutsche Girozentrale opened 0 new positions and closed 11 in Q4 2024.
- DekaBank Deutsche Girozentrale's portfolio value rose 0.32% quarter-over-quarter to $54.1B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2024, filed 29 Jan 2025.